You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

DEMADEX Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Demadex, and when can generic versions of Demadex launch?

Demadex is a drug marketed by Roche and Norvium Bioscience and is included in two NDAs.

The generic ingredient in DEMADEX is torsemide. There are sixteen drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the torsemide profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Demadex

A generic version of DEMADEX was approved as torsemide by STRIDES PHARMA on May 27th, 2003.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for DEMADEX?
  • What are the global sales for DEMADEX?
  • What is Average Wholesale Price for DEMADEX?
Summary for DEMADEX
US Patents:0
Applicants:2
NDAs:2
Raw Ingredient (Bulk) Api Vendors: 126
Clinical Trials: 7
Patent Applications: 4,694
Drug Prices: Drug price information for DEMADEX
What excipients (inactive ingredients) are in DEMADEX?DEMADEX excipients list
DailyMed Link:DEMADEX at DailyMed
Drug patent expirations by year for DEMADEX
Drug Prices for DEMADEX

See drug prices for DEMADEX

Recent Clinical Trials for DEMADEX

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
New York City Health and Hospitals CorporationPhase 4
Sarfez Pharmaceuticals, Inc.Phase 1
Roxane LaboratoriesN/A

See all DEMADEX clinical trials

US Patents and Regulatory Information for DEMADEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche DEMADEX torsemide SOLUTION;INTRAVENOUS 020137-002 Aug 23, 1993 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Norvium Bioscience DEMADEX torsemide TABLET;ORAL 020136-002 Aug 23, 1993 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Roche DEMADEX torsemide SOLUTION;INTRAVENOUS 020137-001 Aug 23, 1993 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Norvium Bioscience DEMADEX torsemide TABLET;ORAL 020136-001 Aug 23, 1993 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Norvium Bioscience DEMADEX torsemide TABLET;ORAL 020136-004 Aug 23, 1993 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Norvium Bioscience DEMADEX torsemide TABLET;ORAL 020136-003 Aug 23, 1993 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for DEMADEX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Norvium Bioscience DEMADEX torsemide TABLET;ORAL 020136-003 Aug 23, 1993 ⤷  Sign Up ⤷  Sign Up
Norvium Bioscience DEMADEX torsemide TABLET;ORAL 020136-002 Aug 23, 1993 ⤷  Sign Up ⤷  Sign Up
Norvium Bioscience DEMADEX torsemide TABLET;ORAL 020136-002 Aug 23, 1993 ⤷  Sign Up ⤷  Sign Up
Roche DEMADEX torsemide SOLUTION;INTRAVENOUS 020137-002 Aug 23, 1993 ⤷  Sign Up ⤷  Sign Up
Norvium Bioscience DEMADEX torsemide TABLET;ORAL 020136-004 Aug 23, 1993 ⤷  Sign Up ⤷  Sign Up
Roche DEMADEX torsemide SOLUTION;INTRAVENOUS 020137-002 Aug 23, 1993 ⤷  Sign Up ⤷  Sign Up
Roche DEMADEX torsemide SOLUTION;INTRAVENOUS 020137-002 Aug 23, 1993 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for DEMADEX

See the table below for patents covering DEMADEX around the world.

Country Patent Number Title Estimated Expiration
Austria A189877 ⤷  Sign Up
Ireland 59237 Process for the preparation of a stable modification of torasemide and pharmaceutical compositions containing it ⤷  Sign Up
Sweden 424320 ANALOGIFORFARANDE FOR FRAMSTELLNING AV DERIVAT AV 3-SULFONAMIDO-4-AMINO-PYRIDINER ⤷  Sign Up
Canada 1307277 MODE DE PREPARATION D'UN DERIVE STABLE DE TORASEMIDE ET COMPOSITIONS CHIMIQUES CONTENANT CE DERIVE (PROCESS FOR THE PREPARATION OF A STABLE MODIFICATION OF TORASEMIDE AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT) ⤷  Sign Up
Austria A189777 ⤷  Sign Up
Yugoslavia 42409 ⤷  Sign Up
European Patent Office 0212537 PROCESS FOR THE PREPARATION OF A STABLE MODIFICATION OF TORASEMIDE, AND MEDICAMENTS CONTAINING TORASEMIDE ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.